To our knowledge, this research represents the preliminary investigation illustrating the interaction between these two molecules, highlighting the roles of ELAVL1 and HMGB3 in the pathogenesis of nasopharyngeal carcinoma. This evidence concerns the gene ELAVL1 and nasopharyngeal carcinoma.